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A trisialoganglioside not found before in human tissue was isolated from human adult lung. Structural char- 
acterization showed this to be I13(NeuAc),-LacCer or GT3. The ganglioside constituted 40% of the trisialo- 
gangliosides of human lung or 0.2 nmol ganglioside per g tissue. 
Mass spectrometry (Human lung) Ganglioside GT3 
1. INTRODUCTION 
In 1979 Avrova et al. [l] demonstrated the 
presence of a trisialosyl lactosylceramide (GT3) in 
the central nervous sytem of elasmobranches. The 
same ganglioside was also isolated from the brain 
of a teleost (cod) and carefully characterized by Yu 
and Ando [2]. They suggested that this ganglioside 
represented the parent compound for a phylo- 
genetically older route of ganglioside biosynthesis. 
Yet, ganglioside GT3 was also found to occur in 
a mammalian tissue, namely hog kidney cortex [3]. 
The yield was high, 6.8 nmol/g tissue or 13 mol% 
of total ganglioside sialic acid. Here, we describe 
the isolation of GT3 from human tissue and con- 
firm its structure by mass spectrometry. 
2. EXPERIMENTAL 
2.1. Materials 
Lung tissue was obtained from several subjects 
aged 40-70 years who had died in accidents. There 
were no macroscopical signs of lung disease. 
Silica gel 60, 70-230 mesh, glass-backed TLC 
and HPLC plates of silica gel G were obtained 
Abbreviations: gangliosides have been designated ac- 
cording to [16] 
from Merck, Darmstadt. Iatrobeads RS 8060, 60 
pm, were from Iatron Chemical Co., Tokyo. The 
anion-exchange resin Spherosil-DEAE-dextran 
was a gift from Institut Merieux, Lyon, France [4]. 
All organic solvents and other chemicals were of 
analytical quality and used without further purifi- 
cation. Vibrio cholerae sialidas (EC 3.2.1.18) was 
from Behringwerke, Marburg-Lahn, FRG. Gan- 
gliosides used as standards and references were all 
isolated in our laboratory. 
2.2. Isolation of gangliosides 
The lung tissue (2000 x g) was homogenized in 2 
vols water in a scissor homogenizer. Then 8 vols 
methanol followed by 4 vols chloroform were add- 
ed under continuous stirring [5]. The supernatant 
was freed from the extracted lung tissue by cen- 
trifugation at 2OOOxg for 30 min. The lung tissue 
was re-extracted with 1 vol. water, 2.5 vols 
methanol and 1.25 vols chloroform to give a final 
chloroform/methanol/water ratio of 4 : 8 : 3 (v/v) 
[5]. After the tissue residue was removed by cen- 
trifugation as before, the combined supernatants 
were evaporated to dryness and dissolved in 2 1 
chloroform/methanol (1: 2, v/v). Upon standing 
overnight, a large precipitate appeared, which was 
removed by centrifugation. The extract was then 
evaporated and dissolved again in the same solvent 
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- this procedure was repeated until only negligible 
precipitate appeared. 
The lipid extract was then divided into two equal 
portions and chromatographed on 2 columns of 
200 g silica gel 60,70-230 mesh. The columns were 
eluted with 10 vols chloroform, 8 vols chloroform/ 
methanol/water (65:25:4, v/v), 5 vols chloro- 
form/methanol/water (60:35:8, v/v) and 15 vols 
chloroform/methanol/water (50: 40: IO, v/v). 
The last fraction contained the complex ganglio- 
sides [6] which were separated into mono-, di- and 
trisialogangliosides by anion-exchange chroma- 
tography on Spherosil-DEAE-dextran [4]. 
Individual gangliosides of the trisialoganglioside 
fraction were isolated by preparative thin-layer 
chromatography in chloroform/methanol/0.25% 
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Fig. 1. HPLC of trisialogangliosides isolated from 
human adult lung. Developing soivent: chloroform/ 
methanol/O.Z5~a aq. KC1 (50:40: 10, v/v). The ganglio- 
sides were visualized with the resorcinol reagent. Lanes: 
1, total trisiaiogangliosides; 2, purified ganglioside GT3; 
3, reference gangliosides. 
aq. KC1 (50:40 : 10, v/v). Two major ganglioside 
bands of almost equal size were isolated (fig.1). 
The slow-migrating ganglioside had the same Rr 
value and composition as authentic GTl b while the 
fast-migrating ganglioside had an RF value which 
did not coincide with any known ganglioside of 
human origin. 
2.3. Structural analyses of the novel 
trisialoganglioside 
Sialic acid was determined using the resorcinol 
assay [7] and sphingosine bases with a modified 
methyl orange method [8]. The carbohydrate com- 
position was quantitatively determined by GLC of 
the corresponding alditol acetates [9]. Sialidase 
and acidic hydrolyses were performed as described 
[lo]. The ganglioside was permethylated by a 
modified procedure of Ciucanu and Kerek [ 111. 
The ganglioside (50 nmol) was dissolved in lOO$ 
dry dimethyl sulfoxide in a small glass tube with a 
teflon-lined screw cap, and 4 mg powdered sodium 
hydroxide and 20 ,& methyl iodide was added 
under nitrogen atmosphere. The capped tube was 
then sonicated at 25°C for 30 min. The per- 
methylated ganglioside was extracted from the 
reaction mixture with chloroform after the addi- 
tion of water, and further purified by repeated par- 
titioning against chloroform. After evaporation, 
the permethylated ganglioside was dissolved in 100 
~11 chloroform and applied to 100 mg Iatrobeads 
packed in a Pasteur pipette with a glass-wool plug. 
The column was eluted with 1 .O ml chloroform and 
2.50 ml chloroform/methanol (95: 5, v/v). The 
second fraction contained the permethylated gan- 
glioside and the purity was checked by HPLC in 
chloroform/methanol (9: 1, v/v) as solvent. For 
checking of the procedure, samples containing 
5-100 nmol of ganglioside GM1 radioactively 
labelled in the ceramide portion were permethyl- 
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Fig.2. Positive ion FAB-MS of permethylated ganglioside GT3. Significant background peaks from the thioglycerol 
matrix were subtracted. 
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ated. The recovery of permethylated ganglioside 
was approx. 80% when the sample range was be- 
tween 5 and 15 nmol and 90% between 15 and 100 
nmol. Partially methylated alditol acetates from 10 
nmol ganglioside were obtained as described [ 121. 
They were analyzed by GLC on a fused silica BP1 
capillary column (SGE, Australia) and by GC-MS 
on a VG 7070 mass spectrometer equipped with a 
VG 11/250 data system (VG Analytical, Man- 
chester, England). Analyses of partially permethyl- 
ated sialic acids were performed as described by 
Rauvala and Kirkkainen f 131. 
FAB-MS was performed on a VG ZAB HF (VG 
Analytical) equipped with a fast atom gun. The 
permethylated ganglioside was dissolved in chloro- 
form/methanol (1: 5, v/v) to give a concentration 
of 1 nmol//rl. The stainless-steel target was coated 
with 2 ~1 of 0.1% sodium acetate in methanol and 
dried. Afterwards 3 /LI thioglycerol and 1 pl of the 
permethylated ganglioside solution were added to 
the target [14]. The target was bombarded with 
xenon atoms having kinetic energies equivalent to 
- 8 keV. Spectra were recorded in the positive ion 
mode by downfield mass controlled linear scans of 
100-300 s duration, The resolution of the instru- 
ment was set to 300 ppm. The spectra were evalu- 
ated by manual counting of the spectral lines. 
3. RESULTS AND DISCUSSION 
The concentration of the unknown trisialogan- 
glioside in the adult human lung was 0.2 nmol gan- 
glioside/g tissue, which is 0.6% of total ganglioside 
sialic acid or 40% of the trisialogangliosides. The 
isolated ganglioside contained sphingosine, N-ace- 
tylneuraminic acid, glucose and galactose in the 
molar ratio 0.9 : 2.6: 1 .O: 1 .O. Hydrolysis with 
sialidase or weak acid yielded lactosylceramide. 
Prolonged acid hydrolysis also produced glucosyl- 
ceramide. Methylation analysis of the intact gan- 
glioside gave 2,4,6-Mes-Gal and 2,3,6- Me3-Glc in 
approximately equimolar amounts. Analyses of 
the desialylated substance gave 2,3,4,6-Med-Gal in- 
stead of 2,3,4-Me3-Gal. Of the partially methylated 
sialic acids 4,7,9-Me3-NeuAcMes and 4,7,8,9-Med- 
NeuAcMe3 were found in a ratio of 1.0: 1.0. 
Analysis of reference gangliosides GD3 and GDlb 
at the same time showed a ratio of 0.6: 1 .O between 
the two sialic acids. The low yield of 4,7,9,-Mes- 
NeuAcMe3 might be explained by the destruction 
of sialic acid during methanolysis [151. 
The FAB mass spectra of the permethylated 
ganglioside showed ions at m/z 376,344 (376 - 32), 
737 and 1098, which indicates the presence of 3 
sialic acids linked together (fig.2). The ceramide 
residue was represented by ions at m/z 660, 658, 
646 and 632. Thus the ceramide consisted mainly 
of C22-C24 fatty acids in combination with 
4-sphingenine. A weak pseudomolecular ion at 
m/z 2205 (M + Na) represented NeuAcxHexz 
Cerzd:o + Na, but ions at m/z 2203, 2191 and 2177 
were also found, corresponding to ceramide por- 
tions containing C24: 1, C23 : 0 and C22:O fatty 
acids. 
The structural analyses of the isolated trisialo- 
ganglioside of human lung showed it to be 
I13NeuAc3LacCer or GT3: 
NeuAcLu2-SNeuAccu2-8NeuAccu2-3Ga~1-4Glc - 
,&l- 1 ceramide. 
ACKNOWLEDGEMENTS 
This study was supported by a grant from the 
Swedish Medical Research Council (project no. 
03X-627). We thank Dr Jasna Peter-Katalinic for 
assistance with the mass spectrometric determina- 
tions. 
REFERENCES 
111 
PI 
131 
141 
PI 
161 
Avrova, N.F., Li, Y.-T. and Obukhova, E.L. 
(1979) J. Neurochem. 32, 1807-1815. 
Yu, R.K. and Ando, S. (1980) Adv. Exp. Med. 
Biol. 125, 33. 
Murakami-Murofushi, K., Tadano, K., Koyama, I. 
and Ishizuka, I. (1981f J. Biochem. 90, 1817-1820. 
Fredman, P., Nilsso, O., Tayot, J.-L. and Svenner- 
helm, L. (1980) Biochim. Biophys. Acta 618, 
42-52. 
Svennerholm, L. and Fredman, P. (1980) Biochim. 
Biophys. Acta 617, 97-109. 
Fredman, P., Nilsson, O., Svennerholm, L., Myr- 
vold, H., Persson, B., Pettersson, S., Holmgren, J. 
and Lindholm, L. (1983) Med. Biol. 61, 45-48. 
[7] Svennerholm, L. (1957) Biochim. Biophys. Acta 
24, 604-611. 
[8] Lauter, C.J. and Trams, E.G. (1962) J. Lipid Res. 
3, 136-138. 
[9] Holm, M., Mansson, J.-E., Vanier, M.-T. and 
Svennerholm, L. (1972) Biochim. Biophys, Acta 
280, 356-364. 
261 
Volume 196, number 2 FEBS LETTERS February 1986 
[lo] Fredman, P., Mansson, J.-E., Svennerholm, L., 
Samuelsson, B., Pascher, I., Pimlott, W., Karlsson, 
K.-A. and Klinghardt, G.W. (1981) Eur. J. Bio- 
them. 116, 553-564. 
[Ill Ciucanu, I. and Kerek, F. (1984) Carbohydr. Res. 
131, 209-217. 
[12] Svennerholm, L., Vanier, M.-T. and Mansson, J.- 
E. (1980) J. Lipid Res. 21, 53-64. 
[ 131 Rauvala, H. and Karkkiinen, J. (1977) Carbohydr. 
Res. 56, 1-9. 
[14] Egge, H., Peter-Katalinic, J., Reuter, G., Schauer, 
R., Ghidoni, R., Sannino, S. and Tettamanti, G. 
(1985) Chem. Phys. Lipids 37, 127-141. 
[15] Inoue, S., Matsumusa, G. and Inoue, Y. (1982) 
Anal. Biochem. 125, 118-124. 
[ 161 IUPAC-IUB Commission on Biochemical Nomen- 
clature (1977) Eur. J. Biochem. 79, 11-21. 
262 
